Zealand Pharma A/S (ZLDPF) Short Interest Ratio & Short Volume $59.56 +2.58 (+4.53%) As of 10:48 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Zealand Pharma A/S Short Interest DataZealand Pharma A/S (ZLDPF) has a short interest of 1.16 million shares, representing 1.64% of the float (the number of shares available for trading by the public). This marks a -6.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 611.4, indicating that it would take 611.4 days of the average trading volume of 940 shares to cover all short positions.Current Short Interest1,161,600 sharesPrevious Short Interest1,244,100 sharesChange Vs. Previous Month-6.63%Dollar Volume Sold Short$81.40 millionShort Interest Ratio611.4 Days to CoverLast Record DateJune 15, 2025Outstanding Shares71,024,000 sharesShort Percent of Float1.64%Today's Trading Volume150 sharesAverage Trading Volume940 sharesToday's Volume Vs. Average16% Short Selling Zealand Pharma A/S? Sign up to receive the latest short interest report for Zealand Pharma A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZLDPF Short Interest Over TimeZLDPF Days to Cover Over TimeZLDPF Percentage of Float Shorted Over Time Zealand Pharma A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,161,600 shares $81.40 million -6.6%1.6%611.4 $70.08 5/31/20251,244,100 shares $87.65 million -4.0%1.8%3110.3 $70.45 5/15/20251,295,800 shares $78.35 million -6.9%1.8%682 $60.46 4/30/20251,391,300 shares $100.56 million +0.1%N/A927.5 $72.28 4/15/20251,390,600 shares $91.94 million +5.2%2.0%632.1 $66.12 3/31/20251,321,800 shares $99.93 million +6.5%1.9%3304.5 $75.60 3/15/20251,241,700 shares $104.92 million -31.5%1.7%344.9 $84.50 2/28/20251,811,500 shares $177.13 million +1.0%2.6%6038.3 $97.78 2/15/20251,793,300 shares $186.52 million +12.9%2.5%4483.3 $104.01 1/31/20251,588,400 shares $161.24 million +28.4%N/A794.2 $101.51 Get the Latest News and Ratings for ZLDPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,237,500 shares $117.92 million +6.1%N/A825 $95.29 12/31/20241,166,300 shares $119.38 million +39.7%N/A555.4 $102.36 12/15/2024835,100 shares $94.24 million +2.7%N/A596.5 $112.85 11/30/2024813,400 shares $84.63 million +0.1%N/A135.6 $104.05 11/15/2024812,300 shares $82.85 million -0.1%N/A290.1 $102.00 10/31/2024812,800 shares $93.47 million +0.3%N/A239.1 $115.00 10/15/2024810,600 shares $92.69 million +2.2%N/A386 $114.35 9/30/2024793,400 shares $97.19 million +5.0%N/A466.7 $122.50 9/15/2024755,300 shares $103.29 million +1.9%N/A302.1 $136.76 8/31/2024741,400 shares $93.42 million -0.1%N/A741.4 $126.00 8/15/2024741,900 shares $101.63 million -0.6%N/A570.7 $136.99 7/31/2024746,000 shares $99.23 million +21.4%N/A310.8 $133.01 7/15/2024614,500 shares $83.28 million +0.5%N/A120.5 $135.52 6/30/2024611,300 shares $79.07 million +2.8%N/A59.3 $129.35 6/15/2024594,600 shares $54.98 million +8.0%N/A198.2 $92.46 5/31/2024550,400 shares $51.18 million +16.2%N/A220.2 $92.98 5/15/2024473,700 shares $45.15 million +3.6%N/A315.8 $95.30 4/30/2024457,200 shares $41.90 million +11.6%N/A268.9 $91.65 4/15/2024409,800 shares $34.50 million +21.1%N/A102.5 $84.19 3/31/2024338,500 shares $33.85 million +8.4%N/A109.2 $100.00 3/15/2024312,400 shares $31.86 million -1.9%N/A29.5 $101.98 2/29/2024318,500 shares $30.89 million -40.2%N/A23.1 $97.00 2/15/2024532,800 shares $37.59 million -12.2%N/A409.8 $70.54 1/15/2024635,900 shares $40.79 million -10.3%N/A227.1 $64.14 12/31/2023795,700 shares $44.28 million -3.0%N/A723.4 $55.65 12/15/2023795,700 shares $41.34 million -3.0%N/A723.4 $51.95 11/30/2023820,400 shares $40.56 million -6.4%N/A1367.3 $49.44 11/15/2023890,400 shares $37.09 million +4.4%N/A4452 $41.66 10/31/2023890,400 shares $38.14 million +4.4%N/A4452 $42.84 10/15/2023852,800 shares $37.68 million -0.7%N/A8528 $44.18A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 9/30/2023858,400 shares $37.30 million -17.6%N/A2146 $43.46 9/15/20231,041,100 shares $43.44 million -16.9%N/A1735.2 $41.72 8/31/20231,252,100 shares $46.70 million -23.8%N/A8635.1 $37.30 8/15/20231,643,700 shares $58.10 million +3.0%N/A5479 $35.35 7/31/20231,596,100 shares $53.34 million +8.2%N/A7980.5 $33.42 7/15/20231,475,800 shares $49.97 million +23.3%N/A2951.6 $33.86 6/30/20231,196,700 shares $41.35 million +31.6%N/A3989 $34.55 6/15/2023909,700 shares $36.93 million +0.0%N/A3032.3 $40.60 5/31/2023909,400 shares $34.78 million +35.5%N/A1818.8 $38.25 5/15/2023671,300 shares $25.40 million -20.7%N/A559.4 $37.84 4/30/2023847,000 shares $28.69 million -3.9%N/A8470 $33.88 4/15/2023880,900 shares $27.40 million +3.0%N/A8809 $31.11 3/31/2023855,000 shares $29.82 million -1.4%N/A8550 $34.88 3/15/2023866,900 shares $27.75 million +36.0%N/A8669 $32.01 2/28/2023637,500 shares $19.63 million -1.9%N/A3187.5 $30.79 2/15/2023650,100 shares $19.06 million +3.2%N/A928.7 $29.32 1/31/2023630,200 shares $18.91 million -0.4%N/A3151 $30.00 1/15/2023632,600 shares $18.98 million -4.5%N/A3163 $30.00 12/30/2022662,500 shares $18.67 million -0.9%N/A1656.3 $28.18 12/15/2022668,800 shares $18.81 million -0.8%N/A2229.3 $28.12 11/30/2022674,300 shares $18.95 million -3.8%N/A613 $28.10 11/15/2022701,000 shares $18.97 million +9.8%N/A637.3 $27.07 10/31/2022638,500 shares $16.44 million -11.0%N/A912.1 $25.75 10/15/2022717,600 shares $16.72 million -4.5%N/A3588 $23.30 9/30/2022751,500 shares $17.25 million +4.0%N/A1503 $22.95 9/15/2022722,900 shares $13.02 million +1.9%N/A7229 $18.01 8/31/2022709,300 shares $13.58 million -31.5%N/A886.6 $19.15 8/15/20221,035,900 shares $16.98 million +33.5%N/A3453 $16.39 7/31/2022775,900 shares $11.71 million +1.3%N/A0 $15.09 7/15/2022766,000 shares $11.56 million -3.3%N/A3830 $15.09 6/30/2022791,700 shares $9.37 million +0.7%N/A7917 $11.83 6/15/2022786,000 shares $9.39 million -1.3%N/A7860 $11.95 5/31/2022796,200 shares $10.91 million +222.5%N/A7962 $13.70 5/15/2022246,900 shares $2.75 million -12.1%N/A2469 $11.14 4/30/2022280,900 shares $4.35 million +1.9%N/A0 $15.50 4/15/2022275,800 shares $4.27 million +7.9%N/A2758 $15.50 3/31/2022255,700 shares $4.14 million -1.9%N/A319.6 $16.20 3/15/2022260,700 shares $3.74 million +2.5%N/A0 $14.35 2/28/2022254,300 shares $3.65 million +581.8%N/A2543 $14.35 2/15/202237,300 shares $641.56 thousand -1.6%N/A373 $17.20 1/31/202237,900 shares $873.60 thousand -13.5%N/A379 $23.05 1/15/202243,800 shares $1.01 million +11.7%N/A73 $23.05 12/31/202139,200 shares $863.97 thousand -37.3%N/A392 $22.04 12/15/202162,500 shares $1.60 million -9.2%N/A0 $25.65 11/30/202168,800 shares $1.76 million -14.5%N/A0 $25.65 11/15/202180,500 shares $2.06 million +6.6%N/A201.3 $25.65 10/29/202175,500 shares $2.39 million +1.2%N/A755 $31.65 10/15/202174,600 shares $2.21 million +16.4%N/A0 $29.65 9/30/202164,100 shares $1.90 million +105.5%N/A641 $29.65 9/15/202131,200 shares $868.92 thousand -40.3%N/A312 $27.85A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 8/31/202152,300 shares $1.46 million +211.3%N/A523 $27.85 8/13/202116,800 shares $485.86 thousand -75.8%N/A0 $28.92 7/30/202169,300 shares $2.00 million +20.1%N/A0 $28.92 7/15/202157,700 shares $1.67 million -16.6%N/A0 $28.92 6/30/202169,200 shares $2.00 million +15.7%N/A692 $28.92 6/15/202159,800 shares $1.95 million +15.0%N/A598 $32.60 5/28/202152,000 shares $1.70 million +7.4%N/A0 $32.60 5/14/202148,400 shares $1.58 million -20.1%N/A484 $32.60 4/30/202160,600 shares $1.98 million -46.3%N/A606 $32.60 4/15/2021112,900 shares $3.68 million +19.7%N/A1129 $32.60 3/31/202194,300 shares $2.96 million +74.6%N/A943 $31.40 3/15/202154,000 shares $1.71 million +12.3%N/A540 $31.65 2/26/202148,100 shares $1.62 million +14.8%N/A481 $33.59 2/12/202141,900 shares $1.41 million +6.6%N/A419 $33.59 1/29/202139,300 shares $1.47 million -19.5%N/A393 $37.50 1/15/202149,200 shares $1.77 million +20.0%N/A0 $35.95 12/31/202075,200 shares $2.70 million +52.9%N/A0 $35.95 12/15/202049,200 shares $1.77 million +20.0%N/A0 $35.95 11/30/202041,000 shares $1.47 million -45.1%N/A136.7 $35.95 10/30/202055,600 shares $1.86 million +3.2%N/A556 $33.40 10/15/202053,900 shares $2.28 million -17.3%N/A179.7 $42.30 9/30/202065,200 shares $2.44 million -39.0%N/A0 $37.40 9/15/2020106,800 shares $3.99 million +23.5%N/A0 $37.40 8/31/202086,500 shares $3.24 million +44.7%N/A865 $37.40 8/14/202059,800 shares $2.13 million +16.8%N/A598 $35.63 7/31/202051,200 shares $1.82 million -2.7%N/A256 $35.63 7/15/202052,600 shares $1.81 million +6.5%N/A0 $34.40 ZLDPF Short Interest - Frequently Asked Questions What is Zealand Pharma A/S's current short interest? Short interest is the volume of Zealand Pharma A/S shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 1,161,600 shares of ZLDPF short. 1.64% of Zealand Pharma A/S's shares are currently sold short. Learn More on Zealand Pharma A/S's current short interest. What is a good short interest ratio for Zealand Pharma A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZLDPF shares currently have a short interest ratio of 611.0. Learn More on Zealand Pharma A/S's short interest ratio. What is a good short interest percentage for Zealand Pharma A/S? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.64% of Zealand Pharma A/S's floating shares are currently sold short. Is Zealand Pharma A/S's short interest increasing or decreasing? Zealand Pharma A/S saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,161,600 shares, a decline of 6.6% from the previous total of 1,244,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Zealand Pharma A/S's short interest compare to its competitors? 1.64% of Zealand Pharma A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Zealand Pharma A/S: Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.07%), Genmab A/S Sponsored ADR (0.36%), Dr. Reddy's Laboratories Ltd (1.52%), Moderna, Inc. (18.56%), Viatris Inc. (3.74%), Qiagen N.V. (2.63%), Ascendis Pharma A/S (7.33%), Blueprint Medicines Corporation (5.06%), BridgeBio Pharma, Inc. (13.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Zealand Pharma A/S stock? Short selling ZLDPF is an investing strategy that aims to generate trading profit from Zealand Pharma A/S as its price is falling. ZLDPF shares are trading down $0.77 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Zealand Pharma A/S? A short squeeze for Zealand Pharma A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZLDPF, which in turn drives the price of the stock up even further. How often is Zealand Pharma A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZLDPF, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies ITCI Short Interest GNMSF Short Interest GMAB Short Interest RDY Short Interest MRNA Short Interest VTRS Short Interest QGEN Short Interest ASND Short Interest BPMC Short Interest BBIO Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ZLDPF) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
